Gefitinib Tablet

Get a Price/Quote

Gefitinib Tablet Specification

Indication
Non-Small Cell Lung Cancer (NSCLC)

Salt Composition
Gefitinib 250 mg

Dosage Form
Tablet

Feature
Oral, easy-to-administer, targeted therapy

Ingredients
Gefitinib

Application
Anti-cancer, targeted therapy

Physical Color/Texture
White to off-white film-coated tablets

Shelf Life
24 months

Gefitinib Tablet Trade Information

Minimum Order Quantity
100 box,

Payment Terms
Letter of Credit (L/C), Paypal, Western Union, Cash in Advance (CID), Cash Advance (CA)

Delivery Time
30 Days

Sample Policy
Within a certain price range free samples are available

Main Export Market(s)
Australia, North America, Eastern Europe, Middle East, Western Europe, Africa, Central America, South America, Asia

Certifications
ISO, GMP, WHO

About Gefitinib Tablet

Gefitinib Tablet

Product Description

We Rewine Pharmaceutical are a leading Manufacturer and Exporter of Gefitinib Tablet in different strength and packing. Our manufacturing facility is certified with WHO-GMP.
Geftinat contains gefitinib and belongs to a class of called epidermal growth factor receptor (egfr) tyrosine kinase inhibitors. Geftinat is used for the treatment of non-small cell lung .

Composition: Gefitinib 250 mg Tablet

Specifications:

Brand Name : Gefitinib
Generic Name : Gefitinib
Company : Astra Zeneca
Strength : 250mg
Packing : 3x10
Type : Tablets
Product Type : Finished Product
Usage: Clinical,Hospit

We manufacture and export our brand.We also offer private labeling, Contract manufacturing service.

Targeted Therapy for NSCLC

Gefitinib Tablets are designed to provide targeted treatment for patients diagnosed with Non-Small Cell Lung Cancer (NSCLC). By specifically inhibiting key growth receptors in cancer cells, this oral medication helps halt the progression of disease and offers a tailored approach compared to traditional chemotherapy.

Convenient Oral Administration

These tablets are meant for easy and consistent oral administration, making them straightforward for patients to use at home. Each strip contains 10 film-coated tablets, simplifying dosage management and ensuring compliance with prescribed therapy.

Quality, Stability, and Shelf Life

Gefitinib Tablets have a shelf life of 24 months when stored correctly in a cool and dry environment. The robust packaging and film-coating preserve tablet efficacy, allowing you to maintain the medications quality throughout its intended duration.

FAQs of Gefitinib Tablet:

Q: How should Gefitinib Tablets be administered for NSCLC?

A: Gefitinib Tablets are taken orally, typically once daily at a fixed dose of 250 mg per tablet, as directed by a physician. The tablet can be taken with or without food, but consistent timing enhances efficacy.

Q: What is the recommended storage condition for Gefitinib Tablets?

A: Store Gefitinib Tablets in a cool and dry place, away from direct sunlight and moisture, to preserve their potency. Avoid keeping them in humid environments such as bathrooms.

Q: When is Gefitinib indicated for patient therapy?

A: Gefitinib is prescribed for adult patients diagnosed with Non-Small Cell Lung Cancer (NSCLC), particularly as a targeted therapy in cases where specific genetic mutations are detected. A physician will determine suitability based on clinical evaluation.

Q: Where does one obtain Gefitinib Tablets, and is a prescription necessary?

A: Gefitinib Tablets are available from authorized exporters, manufacturers, and suppliers in India. A physicians prescription is required, as this is not an over-the-counter medication due to its potent, targeted nature.

Q: What is the main benefit of using Gefitinib Tablets in NSCLC treatment?

A: The primary benefit is targeted inhibition of cancer cell growth with lower impact on normal tissues, which reduces some side effects compared to conventional chemotherapy and provides tailored therapy for eligible patients.